Job description
As our Clinician In-Residence, you will be the medical voice across product, clinical operations, regulatory strategy, patient experience, and research as we bring breath-based cancer detection to the world.
About the Role
This is a cross-functional medical role, involving work across product, clinical operations, medical affairs, regulatory, patient experience, and research. Dognosis runs a multi-site prospective clinical study under ICH-GCP and Indian GCP compliance, and is preparing for commercial rollout. You will be embedded across both: shaping protocols and ensuring scientific rigor today, and helping build the medical foundation for a consumer screening product tomorrow.
What You'll Do
Shape study protocols and clinical workflows alongside the Clinical & Founding Team. Shape the user experience and customer journey for our breath-based product(s) for MCED (multi-cancer early detection) and recurrence monitoring. Build and iterate on the counselling workflow for Breath. Easy users on their screening results and serve as the medical point of contact for patient-facing interactions.
Contribute to research publications and represent Dognosis at scientific conferences. What You Need MBBS with registration to practice in India, and ideally in Karnataka. Strong communication skills. You can explain complex medical concepts in simple terms to customers and the general public, while retaining strong clinical confidence with clinicians.
Genuine interest in product development. You want to shape how diagnostics reach people. Comfort in unstructured environments where you define your own priorities and work across functions. Interest in research and figuring out novel care pathways.
Nice to have
Experience in clinical research, whether during training, residency, or independently. Experience in public-facing community (blog, social media, educational content). Experience in product development. What You'll Get Potential co-authorship on research in top-tier journals. Dognosis has been published in the Journal of Clinical Oncology and presents frequently at ASCO, AACR, Cancer Research UK.
Network and interactions with leading hospitals in India and the USA (Narayana Health, KMCRI, Tata Memorial, Harvard's Dana-Farber Cancer Institute) and globally renowned researchers. Competitive salary and matching perks at a company backed by Accel, Berkeley's The House Fund, and other leading global investors. Working with a high-touch interdisciplinary team spanning engineers, scientists, and working detection dogs.
The office is never boring. Ownership over a novel product with potential for a paradigm-shift in oncology and how we detect and treat cancer.